Provided by Tiger Trade Technology Pte. Ltd.

Abeona Therapeutics

5.98
+0.13002.22%
Post-market: 5.94-0.0400-0.67%19:30 EDT
Volume:683.83K
Turnover:4.06M
Market Cap:341.15M
PE:-5.34
High:6.00
Open:5.80
Low:5.79
Close:5.85
52wk High:7.65
52wk Low:4.00
Shares:57.05M
Float Shares:36.92M
Volume Ratio:0.77
T/O Rate:1.85%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.1200
EPS(LYR):1.01
ROE:-43.13%
ROA:-24.55%
PB:2.66
PE(LYR):5.92

Loading ...

Abeona Therapeutics Inc Expected to Post a Loss of 23 Cents a Share - Earnings Preview

Reuters
·
Aug 11

Abeona’s New Phase 4 Wound Study: What ABEO Investors Should Watch

TIPRANKS
·
Aug 07

Abeona Therapeutics Schedules Conference Call on Q2 2026 Results

Reuters
·
Aug 06

CMS Grants NTAP Reimbursement Status for Abeona Gene Therapy Zevaskyn Under Fy2027 IPPS Rule

Reuters
·
Aug 04

Abeona Therapeutics Grants 10,800 Restricted Shares to New Hires Under NASDAQ Inducement Rule

Reuters
·
Aug 03

Abeona Therapeutics® Announces New Employee Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS
·
Aug 03

Abeona Therapeutics Executives Make Bold Moves With Fresh Insider Stock Sales

TIPRANKS
·
Jul 10

Abeona Therapeutics Insider Move Sparks Fresh Interest From Investors

TIPRANKS
·
Jul 03

Abeona Director Leila Alland Disposes of 11,000 Common Shares Worth $65,087

Reuters
·
Jul 03

Abeona Therapeutics Grants up to 9,000 Restricted Shares to Five New Hires Under Inducement Plan

Reuters
·
Jul 01

Abeona Therapeutics® Announces New Employee Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS
·
Jul 01

Top Growth Companies With Strong Insider Ownership For June 2026

Simply Wall St.
·
Jun 22

Abeona Therapeutics shareholders elect Goldan, Zeiher as Class 1 directors

Reuters
·
Jun 13

Abeona Therapeutics director Michael Amoroso resigns from board, committee roles

Reuters
·
Jun 12

Abeona Therapeutics Updates Investor Presentation Under Regulation FD

TIPRANKS
·
Jun 11

Abeona CFO Joseph Vazzano disposes of 49,338 common shares worth $266,815

Reuters
·
Jun 10

BRIEF-Abeona Therapeutics Holds Pre-IND Meeting With FDA For ABO-701 In Prostate Cancer - SEC Filing

Reuters
·
Jun 04

Abeona Therapeutics - Targets Ind Submission for Abo-701 in 2027 - SEC Filing

THOMSON REUTERS
·
Jun 04

Vogo shareholders vote on ratifying Jean Ferrier as board director June 18

Reuters
·
Jun 04

Abeona Therapeutics grants 13,800 restricted shares to seven new hires under inducement plan

Reuters
·
Jun 01